Bioengineered Protein Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
LONDON, Aug. 16, 2017 /PRNewswire/ -- Global Bioengineered Protein Drugs Market: Overview
This report provides in-depth region wise and country wise analysis of the bioengineered protein drugs market. Stakeholders of this report include manufacturers of bioengineered protein drugs, raw material suppliers, research institutes involve in the research of bioengineered protein drugs and new players planning to enter the market.
Download the full report: https://www.reportbuyer.com/product/5064697/
The report provides qualitative and quantitative analysis of the global bioengineered protein drugs market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global bioengineered protein drugs market in major countries globally such as the U.S., Canada, Germany, Italy, France, United Kingdom, Spain, Japan, China, Brazil, Mexico, South Africa and GCC countries.
Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the bioengineered protein drugs with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global bioengineered protein drugs market. These factors would aid the stakeholders in establishing a strong foothold in the global bioengineered protein drugs market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the bioengineered protein drugs market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Global Bioengineered Protein Drugs Market: Segmentation
The bioengineered protein drugs market has been segmented as by drug type, by disease condition, by end-user and by geography. Based on drug type, the market has been segmented into monoclonal antibodies (Humira, Rituxan, Avastin, Herceptin, Remicade, Lucentis, Enbrel, Synazis, and Others) therapeutic proteins (hormones, cytokines, blood factor, enzyme therapy, thrombolytics, and others) vaccines. Based on disease condition, the market has been segmented into cancer, diabetes, autoimmune disorder, infectious disease, hematopoiesis, CVD, neurodegenerative, and others. Based on end-user, the market has been segmented into pharmaceutical & biotechnology companies, CROs, research institutes.
Global Bioengineered Protein Drugs Market: Geographical Analysis
Geographically, the bioengineered protein drugs market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, Italy, France, U.K., Spain, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, GCC countries have also been provided in the report.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the bioengineered protein drugs market in various regions has been provided in this section.
This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.
Global Bioengineered Protein Drugs Market: Competitive Analysis
The report provides a detailed outline/blueprint of the bioengineered protein drugs market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players.
The major players that are profiled in the report include Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Merck & Co., Inc., Reliance Life Sciences Pvt. Ltd., Panacea Biotech, ProBioGen AG, GlaxoSmithKline plc., and F. Hoffmann-La Roche Ltd
The global Bioengineered Protein Drugs market has been segmented into:
Global Bioengineered Protein Drugs Market, by Drug Type
Monoclonal Antibodies
Humira
Rituxan
Avastin
Herceptin
Remicade
Lucentis
Enbrel
Synazis
Others
Therapeutic Proteins
Hormones
Cytokines
Neupogen
Neulasta
Interferon Alpha
Erythropoietin Alpha
Interleukin
Others
Blood Factor
Enzyme Therapy
Systemic Enzyme Therapy
Digestive Enzyme Therapy
Thrombolytics
tPA
Streptokinase
Urokinase
Vaccines
Global Bioengineered Protein Drugs Market, by Disease Condition
Cancer
Diabetes
Autoimmune Disorder
Infectious Disease
Hematopoiesis
CVD
Neurodegenerative
Others
Global Bioengineered Protein Drugs Market, by End-user
Pharma and Biotech Companies
CROs
Academics
Global Bioengineered Protein Drugs Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
Japan
China
India
Australia
Rest of APAC
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa (MEA)
GCC Countries
South Africa
Download the full report: https://www.reportbuyer.com/product/5064697/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article